Published date: 18 January 2023

This notice was replaced on 18 January 2023

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 18 January 2023)

Awarded contract - This means that the contract has been awarded to a supplier.


Contract summary

Industry

  • Health services - 85100000

Location of contract

LS2 7UE

Value of contract

£33,850

Procurement reference

CF-1282600D0O000000rwimUAA

Published date

18 January 2023

Closing date

1 November 2022

Closing time

12pm

Contract start date

11 November 2022

Contract end date

11 February 2023

Contract type

Service contract

Procedure type

Open procedure (below threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements below the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Yes

Description

The scale of the responsibility, and the complexity within which this role operates, will require an individual of significant commercial experience in innovative and generic medicines markets, who will bring the blend of leadership, strategy, science, and commercial skills that can drive the system forwards to benefit patients, healthcare providers and purchasing stakeholders.

More information

Attachments

Award information

Awarded date

22 December 2022

Contract start date

11 November 2022

Contract end date

11 February 2023

Total value of contract

£33,850

This contract was awarded to 1 supplier.

Gatenby Sanderson Limited

Address

14 King Street
Leeds
LS1 2HL LS1 2HL

Reference

None

About the buyer

Contact name

Chris Marston

Address

Quarry Hill
Leeds
LS2 7UE
GB

Email

chris.marston@nhs.net